Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2003, the company has made significant strides in developing innovative therapies for patients with unmet medical needs, particularly in the fields of central nervous system disorders and sleep disorders. Vanda's core products, including the FDA-approved medications Fanapt and Hetlioz, are distinguished by their unique mechanisms of action and targeted therapeutic approaches. The company has established a strong market position, recognised for its commitment to advancing treatment options and improving patient outcomes. With a focus on research and development, Vanda continues to explore new avenues for growth and innovation in the pharmaceutical landscape.
DitchCarbon Score
How does Vanda Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vanda Pharmaceuticals Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vanda Pharmaceuticals Inc.'s reported carbon emissions
Vanda Pharmaceuticals Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Companies are encouraged to adopt science-based targets and engage in initiatives that promote environmental responsibility. Vanda Pharmaceuticals may be exploring such avenues to align with industry standards and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vanda Pharmaceuticals Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
